- Report
- August 2020
- 142 Pages
Global
From €4282EUR$4,500USD£3,666GBP
- Report
- July 2022
- 176 Pages
Global
From €3288EUR$3,456USD£2,815GBP
- Report
- July 2022
- 280 Pages
Global
From €3288EUR$3,456USD£2,815GBP
- Report
- May 2023
- 147 Pages
Global
From €5708EUR$5,999USD£4,887GBP
- Book
- February 2024
- 640 Pages
- Book
- October 2020
- 288 Pages
- Book
- October 2019
- 632 Pages
- Book
- January 2016
- 368 Pages
- Book
- May 2014
- 256 Pages
- Book
- May 2013
- 400 Pages
- Book
- March 2010
- 512 Pages
Colorectal cancer is a type of cancer that affects the colon and rectum. It is the third most common type of cancer in the world and is the second leading cause of cancer-related deaths in the United States. Treatment for colorectal cancer typically involves surgery, chemotherapy, and radiation therapy. In recent years, targeted therapies and immunotherapies have been developed to treat colorectal cancer.
The oncology market for colorectal cancer is highly competitive, with a number of companies offering treatments and therapies. These include pharmaceutical companies such as Merck, Bristol-Myers Squibb, and Roche, as well as biotechnology companies such as ImmunoGen, Exelixis, and Incyte. Additionally, medical device companies such as Medtronic and Boston Scientific are involved in the development of treatments for colorectal cancer. Show Less Read more